HIV-integrase inhibitors, pharmaceutical compositions, and methods for their use
US7001912B2 · kind B2 · utility
8Cited by
4References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 2004 |
| Grant date | Feb 21, 2006 |
| Priority date | — |
| Expiry date | Feb 11, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Beta-carboline hydroxamic acid compounds represented by formula (I) are described. The beta-carboline hydroxamic acid compounds and compositions containing those compounds may be used to inhibit or modulate the activity of HIV integrase enzyme and to treat HIV integrase-mediated diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.